Staphylococcus aureus protects its immune‐evasion proteins against degradation by neutrophil serine proteases
暂无分享,去创建一个
M. Köckritz-Blickwede | M. Horsburgh | J. Strijp | S. Rooijakkers | A. Kuipers | K. Kessel | D. Stapels | A. Tromp | C. J. C. Haas | M. Ruyken | C. J. Haas
[1] V. Rutten,et al. Bovine Staphylococcus aureus Secretes the Leukocidin LukMF′ To Kill Migrating Neutrophils through CCR1 , 2015, mBio.
[2] K. Ramyar,et al. Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors , 2014, Proceedings of the National Academy of Sciences.
[3] Evelien T. M. Berends,et al. Distinct localization of the complement C5b‐9 complex on Gram‐positive bacteria , 2013, Cellular microbiology.
[4] R. Nijland,et al. Neutrophils versus Staphylococcus aureus: a biological tug of war. , 2013, Annual review of microbiology.
[5] F. Vandenesch,et al. The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. , 2013, Cell host & microbe.
[6] P. Zipfel,et al. Staphylococcus aureus Proteins Sbi and Efb Recruit Human Plasmin to Degrade Complement C3 and C3b , 2012, PloS one.
[7] Oliver Schilling,et al. NSP4, an elastase-related protease in human neutrophils with arginine specificity , 2012, Proceedings of the National Academy of Sciences.
[8] L. Miller,et al. Immunity against Staphylococcus aureus cutaneous infections , 2011, Nature Reviews Immunology.
[9] M. Horwitz,et al. Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases , 2010, Pharmacological Reviews.
[10] J. Köhl,et al. Functional basis for complement evasion by staphylococcal superantigen‐like 7 , 2010, Cellular microbiology.
[11] A. Horswill,et al. agr-Dependent Interactions of Staphylococcus aureus USA300 with Human Polymorphonuclear Neutrophils , 2010, Journal of Innate Immunity.
[12] J. V. van Strijp,et al. A Homolog of Formyl Peptide Receptor-Like 1 (FPRL1) Inhibitor from Staphylococcus aureus (FPRL1 Inhibitory Protein) That Inhibits FPRL1 and FPR1 , 2009, The Journal of Immunology.
[13] J. Weiser,et al. Human Neutrophils Kill Streptococcus pneumoniae via Serine Proteases1 , 2009, The Journal of Immunology.
[14] M. Hijnen,et al. Identification of conformational epitopes for human IgG on Chemotaxis inhibitory protein of Staphylococcus aureus , 2009, BMC Immunology.
[15] S. Lindman,et al. Purification of truncated and mutated Chemotaxis Inhibitory Protein of Staphylococcus aureus--an anti-inflammatory protein. , 2009, Protein expression and purification.
[16] S. Achilefu,et al. Neutrophil Elastase Mediates Innate Host Protection against Pseudomonas aeruginosa1 , 2008, The Journal of Immunology.
[17] Eric P. Skaar,et al. Neutrophil Microbicides Induce a Pathogen Survival Response in Community-Associated Methicillin-Resistant Staphylococcus aureus1 , 2008, The Journal of Immunology.
[18] J. Köhl,et al. Staphylococcal complement evasion by various convertase-blocking molecules , 2007, The Journal of experimental medicine.
[19] P. Gros,et al. Staphylococcal Complement Inhibitor: Structure and Active Sites1 , 2007, The Journal of Immunology.
[20] P. Lenting,et al. Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling. , 2007, Blood.
[21] J. V. van Strijp,et al. A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 11 , 2006, The Journal of Immunology.
[22] W. V. van Wamel,et al. Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus , 2006, Cellular microbiology.
[23] K. Preissner,et al. Suppression of experimental autoimmune encephalomyelitis by extracellular adherence protein of Staphylococcus aureus , 2006, The Journal of experimental medicine.
[24] R. Liskamp,et al. The structure of the C5a receptor-blocking domain of chemotaxis inhibitory protein of Staphylococcus aureus is related to a group of immune evasive molecules. , 2005, Journal of molecular biology.
[25] Robert B Sim,et al. Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases , 2005, Nature Immunology.
[26] Adam Zemla,et al. The Crystal Structures of EAP Domains from Staphylococcus aureus Reveal an Unexpected Homology to Bacterial Superantigens* , 2005, Journal of Biological Chemistry.
[27] R. Liskamp,et al. N-Terminal Residues of the Chemotaxis Inhibitory Protein of Staphylococcus aureus Are Essential for Blocking Formylated Peptide Receptor but Not C5a Receptor , 2004, The Journal of Immunology.
[28] E. Prossnitz,et al. Chemotaxis Inhibitory Protein of Staphylococcus aureus Binds Specifically to the C5a and Formylated Peptide Receptor , 2004, The Journal of Immunology.
[29] J. Schröder,et al. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a‐dependent neutrophil enzyme release and chemotaxis , 2004, Experimental dermatology.
[30] A. Zychlinsky,et al. Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.
[31] Andreas Peschel,et al. Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent , 2004, The Journal of experimental medicine.
[32] S. Bahr,et al. Neutrophil Serine Proteinases Cleave Bacterial Flagellin, Abrogating Its Host Response-Inducing Activity 1 , 2004, The Journal of Immunology.
[33] N. Borregaard,et al. Neutrophil granules and secretory vesicles in inflammation. , 2003, Microbes and infection.
[34] L. Juliano,et al. Discriminating between the Activities of Human Neutrophil Elastase and Proteinase 3 Using Serpin-derived Fluorogenic Substrates* , 2002, The Journal of Biological Chemistry.
[35] S. Shapiro,et al. Neutrophil elastase targets virulence factors of enterobacteria , 2002, Nature.
[36] Giorgio Gabella,et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux , 2002, Nature.
[37] K. Botzenhart,et al. Effects of Amoxicillin, Gentamicin, and Moxifloxacin on the Hemolytic Activity of Staphylococcus aureus In Vitro and In Vivo , 2001, Antimicrobial Agents and Chemotherapy.
[38] S. Shapiro,et al. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. , 2000, Science.
[39] T. Ley,et al. Normal neutrophil function in cathepsin G-deficient mice. , 1999, Blood.
[40] A. Conde. Staphylococcus aureus infections. , 1998, The New England journal of medicine.
[41] Ronald McCarthy,et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis , 1998, Nature Medicine.
[42] J. Verhoef,et al. Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils. , 1991, Journal of immunology.
[43] P. Ward,et al. Chemotactic factor inactivators of human granulocytes. , 1977, The Journal of clinical investigation.
[44] F. Laurent,et al. Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.